Zika virus non-coding RNAs antagonize antiviral responses by PKR-mediated translational arrest

Horacio M Pallarés,María Mora González López Ledesma,Santiago Oviedo-Rouco,Luciana A Castellano,Guadalupe S Costa Navarro,Ana J Fernández-Alvarez,María Josefina D'Andreiz,Victor Daniel Aldas-Bulos,Diego E Alvarez,Ariel A Bazzini,Andrea V Gamarnik
DOI: https://doi.org/10.1093/nar/gkae507
IF: 14.9
2024-06-26
Nucleic Acids Research
Abstract:Zika virus (ZIKV) is an emerging mosquito-borne flavivirus that causes severe outbreaks in human populations. ZIKV infection leads to the accumulation of small non-coding viral RNAs (known as sfRNAs) that are crucial for evasion of antiviral responses and for viral pathogenesis. However, the mechanistic understanding of how sfRNAs function remains incomplete. Here, we use recombinant ZIKVs and ribosome profiling of infected human cells to show that sfRNAs block translation of antiviral genes. Mechanistically, we demonstrate that specific RNA structures present in sfRNAs trigger PKR activation, which instead of limiting viral replication, enhances viral particle production. Although ZIKV infection induces mRNA expression of antiviral genes, translation efficiency of type I interferon and interferon stimulated genes were significantly downregulated by PKR activation. Our results reveal a novel viral adaptation mechanism mediated by sfRNAs, where ZIKV increases its fitness by repurposing the antiviral role of PKR into a proviral factor.
biochemistry & molecular biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: **How do the small non - coding RNAs (sfRNAs) of Zika virus (ZIKV) antagonize the host's antiviral response through PKR - mediated translational inhibition?** Specifically, the researchers focused on how the sfRNAs generated during ZIKV infection affect the translation mechanism of host cells, especially how these sfRNAs activate PKR (protein kinase R) and then inhibit the translation of antiviral genes. Through this mechanism, ZIKV can reuse PKR, which was originally used to inhibit virus replication, to promote virus replication and spread instead. ### Main findings: 1. **Accumulation of sfRNAs inhibits the translation of antiviral genes**: By using recombinant ZIKV virus strains that can produce or not produce sfRNAs, the researchers found that the presence of sfRNAs significantly reduced the translation efficiency of type I interferon (IFN) and interferon - stimulated genes (ISGs). 2. **sfRNAs activate PKR**: Specific RNA structures exist in sfRNAs, and these structures can trigger the autophosphorylation of PKR, which instead of limiting virus replication, enhances the production of virus particles. 3. **Reuse of PKR**: ZIKV activates PKR through sfRNAs, thereby inhibiting the translation of antiviral genes, enabling the virus to replicate more effectively in host cells. This mechanism reveals how ZIKV turns the original antiviral pathway into a pathway favorable to the virus. ### Significance: This study not only enhances the understanding of how ZIKV evades the host immune response, but also may provide clues for the development of new antiviral strategies. In particular, by targeting PKR or its downstream signaling pathways, new methods for inhibiting ZIKV replication may be found. ### Conclusion: ZIKV activates PKR through sfRNAs, inhibits the translation of antiviral genes, and thus enhances its adaptability and replication ability. This mechanism shows how viruses cleverly use the host's antiviral defense system to promote their own survival and spread.